Rossari Biotech Reports Record Sales and Operating Profit Amid Income Sustainability Concerns in March 2025
Rossari Biotech has reported its highest quarterly net sales of Rs 579.56 crore for the quarter ending March 2025, alongside an operating profit of Rs 69.49 crore. The company also noted a rise in non-operating income to Rs 1.79 crore, raising concerns about its sustainability.
Rossari Biotech, a small-cap player in the chemicals industry, has recently reported its financial results for the quarter ending March 2025. The company has experienced a notable evaluation change, with its score moving to 3 from -8 over the past three months.The financial data reveals that Rossari Biotech achieved its highest quarterly net sales at Rs 579.56 crore, marking consistent growth each quarter over the last five quarters. This positive trend in sales is complemented by an operating profit (PBDIT) of Rs 69.49 crore, also the highest recorded in the same timeframe, indicating a favorable near-term outlook for operating performance.
However, the company has also reported a quarterly non-operating income of Rs 1.79 crore, which is the highest in the last five quarters. While this increase reflects additional income from non-business activities, there are concerns regarding the sustainability of such income sources.
Overall, Rossari Biotech's recent financial results highlight significant developments in its operational metrics, alongside some caution regarding non-operating income sustainability.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
